Spyglass Pharma, Inc.
Clinical trials sponsored by Spyglass Pharma, Inc., explained in plain language.
-
Glaucoma patients may soon ditch eye drops after cataract surgery
Disease control Recruiting nowThis phase 3 trial tests a bimatoprost implant placed inside the eye during cataract surgery to lower eye pressure in people with glaucoma or high eye pressure. About 400 participants will receive either the implant with a special lens or standard eye drops. The goal is to see if…
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Glaucoma patients may soon ditch eye drops after cataract surgery
Disease control Recruiting nowThis study tests a bimatoprost implant placed inside the eye during cataract surgery to lower eye pressure in people with glaucoma or high eye pressure. About 400 participants will receive either the implant plus a special lens or standard eye drops. The goal is to see if the imp…
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC